Search research articles
Contact Us
Filters
Showing results (401-410 of 797) with videos related to
Page
of 80
Sort By:
Journal of Occupational Rehabilitation
|
November 15, 2023
Clinical Work-Integrating Care in Current Practice: A Scoping Review
Lana Kluit, Coen A M van Bennekom, Annechien Beumer, et al.
The Patient
|
October 19, 2020
Response to Comment on "The Successful Return-To-Work Questionnaire for Cancer Survivors (I-RTW_CS): Development, Validity and Reproducibility"
Michiel A Greidanus, Angela G E M de Boer, Angelique E de Rijk, et al.
Journal of Vascular Surgery
|
September 5, 2006
Conservative versus surgical treatment of venous leg ulcers: a prospective, randomized, multicenter trial
Wijnand B van Gent, Wim C Hop, Marinus C van Praag, et al.
British Journal of Cancer
|
May 1, 1996
Phase II study of a short course of weekly high-dose cisplatin combined with long-term oral etoposide in metastatic colorectal cancer
A S Planting, M E van der Burg, M J van den Bent, et al.
Human Reproduction (Oxford, England)
|
March 5, 2004
Growth hormone secretion is impaired but not related to insulin sensitivity in non-obese patients with polycystic ovary syndrome
Jacoba A M de Boer, Cornelis B Lambalk, Heleen H Hendriks, et al.
Physics in Medicine and Biology
|
August 13, 2008
A scintillating gas detector for 2D dose measurements in clinical carbon beams
E Seravalli, M de Boer, F Geurink, et al.
BMC Cancer
|
July 3, 2010
Enhancing return-to-work in cancer patients, development of an intervention and design of a randomised controlled trial
Sietske J Tamminga, Angela G E M de Boer, Jos H A M Verbeek, et al.
Journal of Pediatric Orthopedics. Part B
|
April 8, 2006
Hip abductor function in adults treated for Perthes disease
Véronique F P Plasschaert, Herwin L D Horemans, Luuk M de Boer, et al.
British Journal of Haematology
|
September 6, 2000
In vitro anti-tumour activity of anti-CD80 and anti-CD86 immunotoxins containing type 1 ribosome-inactivating proteins
A Bolognesi, L Polito, P L Tazzari, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
November 5, 1999
Prolonged skin graft survival by administration of anti-CD80 monoclonal antibody with cyclosporin A
M A Ossevoort, K Lorré, L Boon, et al.
Page
of 80
Search research articles
Search
Showing results (401-410 of 797) with videos related to
Sort By:
Page
of 80
Journal of Occupational Rehabilitation
|
November 15, 2023
Clinical Work-Integrating Care in Current Practice: A Scoping Review
Lana Kluit, Coen A M van Bennekom, Annechien Beumer, et al.
The Patient
|
October 19, 2020
Response to Comment on "The Successful Return-To-Work Questionnaire for Cancer Survivors (I-RTW_CS): Development, Validity and Reproducibility"
Michiel A Greidanus, Angela G E M de Boer, Angelique E de Rijk, et al.
Journal of Vascular Surgery
|
September 5, 2006
Conservative versus surgical treatment of venous leg ulcers: a prospective, randomized, multicenter trial
Wijnand B van Gent, Wim C Hop, Marinus C van Praag, et al.
British Journal of Cancer
|
May 1, 1996
Phase II study of a short course of weekly high-dose cisplatin combined with long-term oral etoposide in metastatic colorectal cancer
A S Planting, M E van der Burg, M J van den Bent, et al.
Human Reproduction (Oxford, England)
|
March 5, 2004
Growth hormone secretion is impaired but not related to insulin sensitivity in non-obese patients with polycystic ovary syndrome
Jacoba A M de Boer, Cornelis B Lambalk, Heleen H Hendriks, et al.
Physics in Medicine and Biology
|
August 13, 2008
A scintillating gas detector for 2D dose measurements in clinical carbon beams
E Seravalli, M de Boer, F Geurink, et al.
BMC Cancer
|
July 3, 2010
Enhancing return-to-work in cancer patients, development of an intervention and design of a randomised controlled trial
Sietske J Tamminga, Angela G E M de Boer, Jos H A M Verbeek, et al.
Journal of Pediatric Orthopedics. Part B
|
April 8, 2006
Hip abductor function in adults treated for Perthes disease
Véronique F P Plasschaert, Herwin L D Horemans, Luuk M de Boer, et al.
British Journal of Haematology
|
September 6, 2000
In vitro anti-tumour activity of anti-CD80 and anti-CD86 immunotoxins containing type 1 ribosome-inactivating proteins
A Bolognesi, L Polito, P L Tazzari, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
November 5, 1999
Prolonged skin graft survival by administration of anti-CD80 monoclonal antibody with cyclosporin A
M A Ossevoort, K Lorré, L Boon, et al.
Page
of 80